Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of donepezil orodispersible tablets 10 mg in healthy Thai volunteers under fasting conditions
TCTR20200428004Phase 0Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Bio-innova. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on TCTR20200428004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200428004.